Learn about the value of digital PCR (dPCR) in clinical research for three different applications:
For each application, Dr. Jan Hellemans analyzes the rationale for dPCR selection and presents relevant case studies.
Hosted by Dr. Jan Hellemans the founder of Biogazelle (now a part of CellCarta) and co-author for digital MIQE guidelines for qPCR and dPCR technologies published in 2020.
Download CellCarta’s case study for an overview on dPCR:
As a global Contract Research Organization Laboratory (CRO) to the biopharmaceutical industry, CellCarta provides access to a broad offering of biomarker platforms and services. We partner with you to address the most complex laboratory testing needs, delivering customized biomarker testing solutions to further the limitless potential of precision medicine.